SCOPUS 정보 검색 플랫폼

Journal of Clinical Pathology

Volumn 53, Issue 10, 2000, Pages 796-797

A paradoxical severe decrease in serum HDL-cholesterol after treatment with a fibrate

(3) Crook, M A a Lynas, J a Wray, R b

a UNIVERSITY HOSPITAL LEWISHAM (United Kingdom)

b East Sussex Healthcare NHS Trust (United Kingdom)

Author keywords

Fibrate; High density lipoprotein cholesterol; Renal function

Indexed keywords

BEZAFIBRATE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; SIMVASTATIN;

ADULT; ARTICLE; CASE REPORT; CHOLESTEROL BLOOD LEVEL; CLINICAL FEATURE; DISEASE COURSE; HEART PROTECTION; HUMAN; HYPERCHOLESTEROLEMIA; HYPOCHOLESTEROLEMIA; INTERSTITIAL NEPHRITIS; MALE; PRIORITY JOURNAL;

ANTILIPEMIC AGENTS; BEZAFIBRATE; CHOLESTEROL, HDL; HUMANS; MALE; MIDDLE AGED; NEPHRITIS, INTERSTITIAL;

EID: 0033779477 PISSN: 00219746 EISSN: None Source Type: Journal
DOI: 10.1136/jcp.53.10.796 Document Type: Article

Times cited : (11)

References (15)

1
- 0028287964
- Ciprofibrate and lipid profile
- 1 Chandler HA, Batchelor AJ. Ciprofibrate and lipid profile. Lancet 1994;344:128-9.
- (1994) Lancet , vol.344 , pp. 128-129
- Chandler, H.A.¹ Batchelor, A.J.²

2
- 0028122539
- Lipid profiles on fibric-acid derivatives
- 2 Capps NE. Lipid profiles on fibric-acid derivatives. Lancet 1994;344:684-5.
- (1994) Lancet , vol.344 , pp. 684-685
- Capps, N.E.¹

3
- 0028106546
- Ciprofibrate and lipid profile
- 3 McLeod AJ, Warren CJ, Armitage M. Ciprofibrate and lipid profile. Lancet 1994;344:955.
- (1994) Lancet , vol.344 , pp. 955
- McLeod, A.J.¹ Warren, C.J.² Armitage, M.³

4
- 0030026319
- Abnormal lipid profiles on fibrate derivatives
- 4 McLeod AJ, Warren CJ, Armitage M. Abnormal lipid profiles on fibrate derivatives. Lancet 1996;347;261.
- (1996) Lancet , vol.347 , pp. 261
- McLeod, A.J.¹ Warren, C.J.² Armitage, M.³

5
- 0029990153
- Paradoxical HDL density lipoprotein reduction induced by fenofibrate and ciprofibrate
- 5 Collinson PO, Hjelm CJ, Canepaanson R. Paradoxical HDL density lipoprotein reduction induced by fenofibrate and ciprofibrate. Ann Clin Biochem 1996;33:159-61.
- (1996) Ann Clin Biochem , vol.33 , pp. 159-161
- Collinson, P.O.¹ Hjelm, C.J.² Canepaanson, R.³

6
- 0030804243
- Paradoxical high density lipoprotein reduction induced by fibrate therapy
- 6 Oleesky DA, Mir MA. Paradoxical high density lipoprotein reduction induced by fibrate therapy. Ann Clin Biochem 1997;34:573-4.
- (1997) Ann Clin Biochem , vol.34 , pp. 573-574
- Oleesky, D.A.¹ Mir, M.A.²

7
- 0031014069
- Fibrates and HDL-cholesterol
- 7 Murphy MJ, Packard CJ, Oreilly DS. Fibrates and HDL-cholesterol. Ann Clin Biochem 1997;34:114.
- (1997) Ann Clin Biochem , vol.34 , pp. 114
- Murphy, M.J.¹ Packard, C.J.² Oreilly, D.S.³

8
- 0027509175
- Severe reversible renal failure with bezafibrate
- 8 Lipkin GW, Thomson CRV. Severe reversible renal failure with bezafibrate. Lancet 1993;341:371.
- (1993) Lancet , vol.341 , pp. 371
- Lipkin, G.W.¹ Thomson, C.R.V.²

9
- 0027531969
- Creatinine rise after fibrate therapy in renal graft recipients
- 9 Devugst O, Goffin E, Pirson Y, et al. Creatinine rise after fibrate therapy in renal graft recipients. Lancet 1993;341; 840.
- (1993) Lancet , vol.341 , pp. 840
- Devugst, O.¹ Goffin, E.² Pirson, Y.³

10
- 0032775406
- Metabolism of apolipoproteins AI and AII in a patient with a paradoxical reduction in high density lipoprotein due to ciprofibrate
- 10 Beghin L, Capps N, Duhal N, et al. Metabolism of apolipoproteins AI and AII in a patient with a paradoxical reduction in high density lipoprotein due to ciprofibrate. Ann Clin Biochem 1999;36;523-5.
- (1999) Ann Clin Biochem , vol.36 , pp. 523-525
- Beghin, L.¹ Capps, N.² Duhal, N.³

11
- 0019858068
- Lipid abnormalities in uraemia, dialysis and transplantation
- 11 Chan MK, Varghes Z, Moorhead JF. Lipid abnormalities in uraemia, dialysis and transplantation. Kidney Int 1981;19: 625-37.
- (1981) Kidney Int , vol.19 , pp. 625-637
- Chan, M.K.¹ Varghes, Z.² Moorhead, J.F.³

12
- 0018221025
- Defective high density lipoprotein composition in patients on chronic haemodialysis. A possible mechanism for accelerated atherosclerosis
- 12 Rapoport J, Aviram M, Chaimovitz C, et al. Defective high density lipoprotein composition in patients on chronic haemodialysis. A possible mechanism for accelerated atherosclerosis. N Engl J Med 1978;299:1326-9.
- (1978) N Engl J Med , vol.299 , pp. 1326-1329
- Rapoport, J.¹ Aviram, M.² Chaimovitz, C.³

13
- 0021240589
- The immunochemical determination of apolipoprotein A, total apolipoprotein A1 and free apolipoprotein A1 in serum of patients with chronic haemodialysis
- 13 Gebhardt DOE, Schmicht IM, Paul LC. The immunochemical determination of apolipoprotein A, total apolipoprotein A1 and free apolipoprotein A1 in serum of patients with chronic haemodialysis. Ann Clin Biochem 1984;21: 301-5.
- (1984) Ann Clin Biochem , vol.21 , pp. 301-305
- Gebhardt, D.O.E.¹ Schmicht, I.M.² Paul, L.C.³

14
- 0023901336
- The effect of renal failure and haemodialysis on the concentration of free apolipoprotein A1 in serum and the implications for the catabolism of high density lipoproteins
- 14 Neary RH, Gowland E. The effect of renal failure and haemodialysis on the concentration of free apolipoprotein A1 in serum and the implications for the catabolism of high density lipoproteins. Clin Chim Acta 1988;171;239-46.
- (1988) Clin Chim Acta , vol.171 , pp. 239-246
- Neary, R.H.¹ Gowland, E.²

15
- 0032506273
- Mechanisms of action of fibrates on lipid and lipoprotein metabolism
- 15 Staels B, Dallongevile J, Auwerk J, et al. Mechanisms of action of fibrates on lipid and lipoprotein metabolism. Circulation 1998;98:2088-93.
- (1998) Circulation , vol.98 , pp. 2088-2093
- Staels, B.¹ Dallongevile, J.² Auwerk, J.³

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.